Karus Therapeutics Ltd.

Karus Therapeutics Ltd.

Karus Therapeutics Ltd.

Date Founded



93 Innovation Drive,Milton Park,Abingdon, Oxfordshire OX14 4RZ

Type of Company


Employees (Worldwide)

11 - 50


Holding Companies

Company Description

Karus Therapeutics Ltd. provides therapies for treatment of cancer and inflammatory diseases. It offers HDAC6 and PI3K inhibitors for the treatment of cancer. The firm’s products in pipeline include KA-2237, KAR4000 Series and KAR3000 Series for the treatment of chronic inflammation, haematological malignancies, and solid tumours. The company was founded in July 2005 by Arasu Ganesan, Graham Keith Packham and Paul Townsend and is headquartered in Abingdon, the United Kingdom.

Contact Data
Trying to get in touch with decision makers at Karus Therapeutics Ltd.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Executive Officer

Executive Chair

Chief Financial Officer

Chief Scientific Officer & Director

Chief Medical Officer

Head of Research & Translational Medicine

Head of Business Development

Head, Toxicology & Safety Pharmacology

Head of Pre-Clinical Development

Paths to Karus Therapeutics Ltd.
Potential Connections via
Relationship Science
Karus Therapeutics Ltd.
Recent Transactions
Details Hidden

IP Group Plc purchases Karus Therapeutics Ltd.

Details Hidden

Novo Ventures is an active manager which provides funding for early and later-stage capital requirements, and provides management support. The firm invests in both public and private companies from Northern Europe and the United States. Novo Ventures targets companies operating in the health technology and health services sector, and industries such as biotechnology and medical specialties. It looks to take minority stake positions in its investments, as well as a seat on the board.

Details Hidden

New Leaf Ventures Partners, LLC is a venture capital firm invests in public and private healthcare technology companies located in the US. The firm target sectors such as biopharmaceutical, information convergence, and life science tool. They provide financing for early and later stage capital requirements.

Details Hidden

SV Health Investors invests in companies located in North America and Europe. The firm targets companies operating in the fields of biotechnology, pharmaceuticals, medical devices & instruments, healthcare services. It provides financing for seed, early, later stage and buyout capital requirements.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Karus Therapeutics Ltd.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Karus Therapeutics Ltd.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Karus Therapeutics Ltd..